12-02-2014
Clariant supports the ocular medicine packaging with launch of new global and compliant standard color range of masterbatches for caps and closures at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, one of the world leaders in specialty chemicals, In the Healthcare sector, coloration of plastics plays an important role in protecting patients by identifying drug types or doses, thereby reducing the risk of errors. However, these plastic packaging materials and the colorants in them need assessment of how they behave in contact with the drug during storage and use. These extractable and leachable studies on the packaging material, play an important role in medium and high risk applications such as ocular medicines, but if something changes in the polymers or masterbatches used to manufacture the packaging, then the data from the extractable and leachable studies may no longer be valid. To address these issues Clariant has used in dedicated expertise to create a new range of standard masterbatch colors, offering the benefits of the MEVOPUR® brand, tailored to the color standard developed by the American Society of Ophthalmology.
12-02-2014
Clariant opens the door for productivity and sustainability in pharmaceutical packaging with European Pharmacopeia tested additives
Muttenz, February 12, 2014 – Clariant, one of the world leaders in specialty chemicals, supports the Healthcare industry with a range of products developed for medical devices and pharmaceutical plastic packaging. With its knowledge, Clariant’s MEVOPUR® nucleant product brings improvements in the process of plastic packaging fabrication. Thanks to them the processing time can be reduced; mechanical properties improved and so companies can save time and increase the productivity. The nucleating agents used in MEVOPUR products are pre-tested using extraction protocols such as those established by US Pharmacopeia, ISO and NEW European Pharmacopeia monograph 3.1.3; the goal is helping companies to meet the challenging regulatory requirements to support “Controlled, Consistent and Compliant”.
12-02-2014
Clariant launches new ‘EP’ masterbatch range for pharmaceutical packaging at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, a world leader in specialty chemicals, Since the launch of the MEVOPUR® range of masterbatch and compounds for Healthcare applications at the end of 2010, Clariant has been active in bring new ideas and products to the market, with the objective of ‘Enhancing Products and Process’ and ‘Protecting the Patient and the Drug’. In particular in the last 12 months, new additive masterbatches have attracted high interest because Clariant had pre-tested the raw materials for the masterbatches using the extraction and biological evaluation protocols of US Pharmacopeia (USP) 23 parts 87 and 88. However initial feed-back raised the question of whether the substances were also listed European Pharmacopeia chapter 3.1.3 (EP 3.1.3). Clariant has reacted to this feed-back and recently completed a test programme on raw materials of its masterbatches, and is now offering products that use raw materials that have been pre-evaluated to both the above USP and EP standards.
12-02-2014
Clariant un-taps creativity potential for the healthcare sector at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, a world leader in specialty chemicals, continues to demonstrate that it is possible to combine creativity with enhanced protection and processing performance for healthcare applications with its sector-dedicated MEVOPUR® polymer and packaging solutions at Pharmapack Europe 2014 Paris (booth 330). MEVOPUR color and performance additives are developed and produced at three ISO 13485 certified and dedicated production facilities located in USA, Europe and Asia to ensure ‘Controlled, Consistent and Compliant’ innovations for the industry.
12-02-2014
Clariant continues investment into new product innovations at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, a world leader in specialty chemicals, continues to demonstrate that it is possible to combine creativity with enhanced protection and processing performance for healthcare applications with its sector-dedicated MEVOPUR® polymer and packaging solutions at Pharmapack Europe 2014 Paris (booth 330). MEVOPUR color and performance additives are developed and produced at three ISO 13485 certified and dedicated production facilities located in USA, Europe and Asia to ensure ‘Controlled, Consistent and Compliant’ innovations for the industry.
11-02-2014
Milliken puts lightweight and sustainability in the spotlight at VDI Plastics in Automotive Engineering 2014
Ghent, Belgium - Milliken will present its innovative high performance reinforcing agent, Hyperform® HPR-803i and its Hyperform® HPN nucleating additives for polyolefins at the VDI's Plastics in automotive engineering conference 2014 in Mannheim, Germany. New application examples will highlight the weight-reduction benefits at Booth #19.
11-02-2014
Belden to Show Broadest Range of Broadcast Solutions at BVE
Venlo, The Netherlands - February 11, 2014 - Belden Inc., a global leader in signal transmission solutions for mission-critical applications, will highlight its most comprehensive range ever of Broadcast solutions at BVE, which is to be held at Excel, London, UK from 25 to 27 February 2014.
11-02-2014
Clariant Divests its Water Treatment Business to South African AECI
Muttenz, February 11, 2014 - Clariant, a world leader in specialty chemicals, today announced that it has signed an agreement to divest the Water Treatment business in Africa to AECI, domiciled in South Africa. The total consideration of the sale amounts to CHF 34 million in cash at closing that is expected by the end of the second quarter 2014. The transaction is subject to certain conditions precedent, as well as regulatory approvals.
